Sanjay Shukla - 21 May 2021 Form 4 Insider Report for aTYR PHARMA INC (LIFE)

Role
President and CEO, Director
Signature
Nancy Denyes, attorney-in-fact
Issuer symbol
LIFE
Transactions as of
21 May 2021
Net transactions value
$0
Form type
4
Filing time
25 May 2021, 21:03:16 UTC
Previous filing
20 May 2021
Next filing
15 Nov 2021
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LIFE Employee Stock Option (Right to buy) Award $0 +207,000 $0.000000 207,000 21 May 2021 Common Stock 207,000 $4.45 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to this option shall vest and become exercisable in 48 equal monthly installments beginning June 21, 2021, such that this option will be fully exercisable on May 21, 2025. This option is subject to accelerated vesting upon termination without cause upon change of control of the issuer.